Novo Probe By U.S. Expands To Insulin Manufacturing
This article was originally published in The Pink Sheet Daily
Massachusetts U.S. Attorney’s office, which is also investigating firm’s marketing, now subpoenas Novo Nordisk for documents relating to potential issues at its plant in Kalundborg, Denmark.
You may also be interested in...
Novo Nordisk has a plan in emerging markets and is sticking to it, as senior executives detailed in the third quarter earnings call.
Federal judge rules against Novartis’ motion to dismiss a whistleblower suit alleging violations of the anti-kickback statute and the False Claims Act, saying the government’s evidence is specific enough to proceed.
AstraZeneca, Merck, Novartis and Sanofi are also under investigation for potential health care fraud.